These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia. Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn P Trans R Soc Trop Med Hyg; 1995; 89(1):78-82. PubMed ID: 7747316 [TBL] [Abstract][Full Text] [Related]
4. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City. Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387 [TBL] [Abstract][Full Text] [Related]
5. Predictors of mortality among HIV-infected women in Kigali, Rwanda. Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389 [TBL] [Abstract][Full Text] [Related]
6. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study. Atalell KA; Birhan Tebeje N; Ekubagewargies DT PLoS One; 2018; 13(5):e0197145. PubMed ID: 29787596 [TBL] [Abstract][Full Text] [Related]
7. Changing sociodemographic and clinical characteristics of tuberculosis among HIV-infected patients, New York City, 1992-2005. Harris TG; Li J; Hanna DB; Munsiff SS Clin Infect Dis; 2010 Jun; 50(11):1524-31. PubMed ID: 20415570 [TBL] [Abstract][Full Text] [Related]
8. Extensively drug-resistant tuberculosis in the United States, 1993-2007. Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626 [TBL] [Abstract][Full Text] [Related]
9. Nonadherence in tuberculosis treatment: predictors and consequences in New York City. Pablos-Méndez A; Knirsch CA; Barr RG; Lerner BH; Frieden TR Am J Med; 1997 Feb; 102(2):164-70. PubMed ID: 9217566 [TBL] [Abstract][Full Text] [Related]
10. Survival in a cohort of human immunodeficiency virus-infected tuberculosis patients in New York City. Implications for the expansion of the AIDS case definition. Stoneburner R; Laroche E; Prevots R; Singh T; Blum S; Terry P; Reatrice S; Adler J Arch Intern Med; 1992 Oct; 152(10):2033-7. PubMed ID: 1358042 [TBL] [Abstract][Full Text] [Related]
11. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study. Podlekareva DN; Efsen AM; Schultze A; Post FA; Skrahina AM; Panteleev A; Furrer H; Miller RF; Losso MH; Toibaro J; Miro JM; Vassilenko A; Girardi E; Bruyand M; Obel N; Lundgren JD; Mocroft A; Kirk O; Lancet HIV; 2016 Mar; 3(3):e120-31. PubMed ID: 26939735 [TBL] [Abstract][Full Text] [Related]
12. Impact of human immunodeficiency virus infection on the outcome of treatment and survival of tuberculosis patients in Mwanza, Tanzania. van den Broek J; Mfinanga S; Moshiro C; O'Brien R; Mugomela A; Lefi M Int J Tuberc Lung Dis; 1998 Jul; 2(7):547-52. PubMed ID: 9661820 [TBL] [Abstract][Full Text] [Related]
13. Multidrug-resistant tuberculosis in patients without HIV infection. Telzak EE; Sepkowitz K; Alpert P; Mannheimer S; Medard F; el-Sadr W; Blum S; Gagliardi A; Salomon N; Turett G N Engl J Med; 1995 Oct; 333(14):907-11. PubMed ID: 7666876 [TBL] [Abstract][Full Text] [Related]
14. The impact of human immunodeficiency virus infection on drug-resistant tuberculosis. Gordin FM; Nelson ET; Matts JP; Cohn DL; Ernst J; Benator D; Besch CL; Crane LR; Sampson JH; Bragg PS; El-Sadr W Am J Respir Crit Care Med; 1996 Nov; 154(5):1478-83. PubMed ID: 8912768 [TBL] [Abstract][Full Text] [Related]
15. [Treatment outcome, survival and their risk factors among new tuberculosis patients co-infected with HIV during the Ebola outbreak in Conakry]. Camara A; Sow MS; Touré A; Diallo OH; Kaba I; Bah B; Diallo TH; Diallo MS; Guilavogui T; Sow OY Rev Epidemiol Sante Publique; 2017 Nov; 65(6):419-426. PubMed ID: 29066256 [TBL] [Abstract][Full Text] [Related]
16. The emergence of drug-resistant tuberculosis in New York City. Frieden TR; Sterling T; Pablos-Mendez A; Kilburn JO; Cauthen GM; Dooley SW N Engl J Med; 1993 Feb; 328(8):521-6. PubMed ID: 8381207 [TBL] [Abstract][Full Text] [Related]
18. Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register. Schnippel K; Shearer K; Evans D; Berhanu R; Dlamini S; Ndjeka N Int J Infect Dis; 2015 Oct; 39():89-94. PubMed ID: 26358856 [TBL] [Abstract][Full Text] [Related]
19. Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study. Marcy O; Tejiokem M; Msellati P; Truong Huu K; Do Chau V; Tran Ngoc D; Nacro B; Ateba-Ndongo F; Tetang-Ndiang S; Ung V; Dim B; Neou L; Berteloot L; Borand L; Delacourt C; Blanche S; Lancet HIV; 2018 Feb; 5(2):e87-e95. PubMed ID: 29174612 [TBL] [Abstract][Full Text] [Related]
20. Long-term Mortality of Patients With Tuberculous Meningitis in New York City: A Cohort Study. Vinnard C; King L; Munsiff S; Crossa A; Iwata K; Pasipanodya J; Proops D; Ahuja S Clin Infect Dis; 2017 Feb; 64(4):401-407. PubMed ID: 27927856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]